AtriCure, Inc. ATRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 154.45M | 153.60M | 141.25M | 140.50M | 134.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 154.45M | 153.60M | 141.25M | 140.50M | 134.27M |
| Cost of Revenue | 35.10M | 34.98M | 31.94M | 35.16M | 32.94M |
| Gross Profit | 119.35M | 118.63M | 109.31M | 105.34M | 101.33M |
| SG&A Expenses | 82.88M | 82.56M | 84.55M | 78.34M | 78.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 150.10M | 143.94M | 140.72M | 138.01M | 134.06M |
| Operating Income | 4.35M | 9.67M | 526.00K | 2.49M | 208.00K |
| Income Before Tax | 4.02M | 9.43M | 394.00K | 2.36M | -86.00K |
| Income Tax Expenses | -47.00K | 471.00K | 286.00K | 604.00K | 181.00K |
| Earnings from Continuing Operations | 4.06M | 8.96M | 108.00K | 1.76M | -267.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.06M | 8.96M | 108.00K | 1.76M | -267.00K |
| EBIT | 4.35M | 9.67M | 526.00K | 2.49M | 208.00K |
| EBITDA | 9.83M | 14.97M | 5.80M | 7.60M | 5.38M |
| EPS Basic | 0.08 | 0.18 | 0.00 | 0.04 | -0.01 |
| Normalized Basic EPS | 0.05 | 0.12 | 0.01 | 0.03 | 0.00 |
| EPS Diluted | 0.08 | 0.18 | 0.00 | 0.04 | -0.01 |
| Normalized Diluted EPS | 0.05 | 0.12 | 0.01 | 0.03 | 0.00 |
| Average Basic Shares Outstanding | 48.89M | 48.67M | 48.33M | 47.96M | 47.92M |
| Average Diluted Shares Outstanding | 49.83M | 48.87M | 49.05M | 48.87M | 47.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |